Lynx1 Capital reports $78,648 Korro Bio common shares purchase
KRRO•Lynx1 Capital increases Korro Bio stake
Lynx1 Capital Management, a 10% owner of Korro Bio, increased its stake through open-market purchases.
- Acquired 6,684 shares at weighted-average prices of $11.40 and $13.19.
- Beneficial ownership rose to 1,544,980 shares, held indirectly.
